The Outcomes of Concomitant Radiation Plus Temozolomide ... - NCI
The Outcomes of Concomitant Radiation Plus Temozolomide ... - NCI
The Outcomes of Concomitant Radiation Plus Temozolomide ... - NCI
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Hanan Shawky, et al. 119<br />
66- Stupp R, Mason WP, van den Bent MJ, Weller M,<br />
Fisher B, Taphoorn MJ, et al. Radiotherapy plus<br />
<strong>Concomitant</strong> and Adjuvant <strong>Temozolomide</strong> for<br />
Glioblastoma. N Engl J Med. 2005, 352: 987-96.<br />
67- Stupp R, Hegi ME, Gilbert MR, Chakravarti A.<br />
Chemoradiotherapy in Malignant Glioma: Standard<br />
<strong>of</strong> Care and Future Directions. J. Clin. Oncol. 2007,<br />
25 (26): 4127-36.<br />
68- Perry J, Laperriere N, Zuraw L, Chmbers A, Spith<strong>of</strong>f<br />
K, Cairncross JG. Adjuvant chemotherapy for adults<br />
with malignant glioma: a systemic review. Can J<br />
Neurol Sci. 2007, 34: 402-10.<br />
69- Sathornsumetee S, Rich JN and Reardon DA. Diagnosis<br />
and treatment <strong>of</strong> high-grade astrocytoma. Neurol Clin.<br />
2007, 25: 1111-39.<br />
70- Cohen MH, Johnson JR and Pazdur R. Food and Drug<br />
Administration Drug Approval Summary:<br />
<strong>Temozolomide</strong> <strong>Plus</strong> <strong>Radiation</strong> <strong>The</strong>rapy for the<br />
Treatment <strong>of</strong> Newly Diagnosed Glioblastoma<br />
Multiforme. Clin. Cancer Res. 2005, 11 (19): 6767-<br />
71.<br />
71- Athanassiou H, Synodinou M, Maragoudakis E,<br />
Paraskevaidis M, Verigos C, Misailidou D, et al.<br />
Randomized Phase II Study <strong>of</strong> <strong>Temozolomide</strong> and<br />
Radiotherapy Compared With Radiotherapy Alone in<br />
Newly Diagnosed Glioblastoma Multiforme. J. Clin.<br />
Oncol. 2005, 23 (10): 2372-7.<br />
72- Glas M, Happold C, Rieger J, Wiewrodt D, Bahr O,<br />
Steinbach JP, et al. Long-Term Survival <strong>of</strong> Patients<br />
With Glioblastoma Treated With Radiotherapy and<br />
Lomustine <strong>Plus</strong> <strong>Temozolomide</strong>. J. Clin. Oncol. 2009,<br />
27: 1257-61.<br />
73- Cairncross G, Berkey B, Shaw E, Jenkins R,<br />
Scheithauer B, Brachman D, et al. Phase III trial <strong>of</strong><br />
chemotherapy plus radiotherapy compared with<br />
radiotherapy alone for pure and mixed anaplastic<br />
oligodendroglioma: Intergroup <strong>Radiation</strong> <strong>The</strong>rapy<br />
Oncology Group Trial 9402. J Clin Oncol. 2006, 24:<br />
2707-14.<br />
74- Corsa P, Parisi S, Raguso A, Troiano M, Perrone A,<br />
Cossa S, et al.. <strong>Temozolomide</strong> and Radiotherapy as<br />
first-line treatment <strong>of</strong> high-grade gliomas. Tumori.<br />
2006, 92: 299-305.<br />
75- Oshiro OS, Tsugu H, Komatsu F, Ohmura T, Ohta M,<br />
Sakamoto S, et al. Efficacy <strong>of</strong> <strong>Temozolomide</strong><br />
Treatment in Patients with High-grade Glioma.<br />
Anticancer Res. 2009, 29: 911-7.<br />
76- Wick W, Platten M and Weller M. New (alternative)<br />
temozolomide regimens for the treatment <strong>of</strong> glioma.<br />
Neuro-oncol, 2009, 11 (1): 69-79.<br />
77- Vogelbaum MA, Berkey B, Peereboom D, Macdonald<br />
D, Giannini C, Suh JH, et al. Phase II trial <strong>of</strong><br />
preirradiation and concurrent temozolomide in patients<br />
with newly diagnosed anaplastic oligodendrogliomas<br />
and mixed anaplastic oligoastrocytomas: RTOG<br />
BR0131. Neuro Oncol. 2009, 11: 167-75.
Change language